Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - procaine penicillin; benzathine penicillin - parenteral liquid/solution/suspension - procaine penicillin antibiotic-penicillin active 150.0 mg/ml; benzathine penicillin antibiotic-penicillin active 115.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - treatment of infection | penicillin sensitive organisms

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 1200000 usp unit - injection, suspension - excipient ingredients: water for injections; sodium citrate; carmellose sodium; povidone; propyl hydroxybenzoate; methyl hydroxybenzoate; lecithin - intramuscular benzathine penicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine penicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g. pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine penicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine penicillin has proven effective in preventing recurrence of these conditions. it has also been used as a follow-up prophylactic therapy for preventing rheumatic heart disease and acute glomerulonephritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 600000 usp unit - injection, suspension - excipient ingredients: carmellose sodium; lecithin; methyl hydroxybenzoate; povidone; propyl hydroxybenzoate; sodium citrate; water for injections - intramuscular benzathine benzylpenicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine benzylpenicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g., pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine benzylpenicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine benzylpenicillin has proven effective in preventing recurrence of these conditions. it has also been used as follow-up prophylactic therapy for rheumatic heart disease and acute glomerulonephritis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - benzathine benzylpenicillin tetrahydrate 442 mg/ml (1,200,000u/2.3ml) - suspension for injection - 1,200,000 u/2.3 ml - active: benzathine benzylpenicillin tetrahydrate 442 mg/ml (1,200,000u/2.3ml) excipient: carmellose sodium lecithin methyl hydroxybenzoate povidone propyl hydroxybenzoate sodium citrate dihydrate water for injection - intramuscular benzathine benzylpenicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine benzylpenicillin: · streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (eg., pharyngitis). · venereal infections - syphilis, yaws, bejel and pinta.

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - procaine benzylpenicillin; dihydrostreptomycin sulphate ; nafcillin sodium - intramammary suspension - 300, 100, 100 mg/syringe - procaine benzylpenicillin, combinations with other antibacterials - cattle - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - benzylpenicillin - powder for solution for injection/infusion - 3000 milligram(s) - benzylpenicillin

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - benzylpenicillin - powder for solution for injection/infusion - 600 milligram(s) - benzylpenicillin

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - benzylpenicillin potassium - powder for solution for infusion or injection - benzylpenicillin potassium 625 mg - antibacterials for systemic use

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - benzylpenicillin potassium - powder for solution for infusion or injection - benzylpenicillin potassium 1250 mg - antibacterials for systemic use

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - nafcillin ; benzylpenicillin procaine 300 mg/3 g; dihydrostreptomycin sulfate 100 mg/3 g - intramammary suspension - 100 mg - 300.000 u - 100 mg - dihydrostreptomycin sulfate 100 mg; nafcillin sodium 100 mg; benzylpenicillin procaine 300000 iu - benzylpenicillin - cattle